Highlights: Early CRISPR treatment showed major cholesterol reduction in just two weeks High-dose therapy led
Vous n'êtes pas connecté
Maroc - MEDINDIA.NET - Medindia Health News - 27/Nov 14:13
A groundbreaking trial shows a one-time CRISPR therapy significantly lowering LDL cholesterol and triglycerides, offering new hope for people with stubborn lipid disorders.
Highlights: Early CRISPR treatment showed major cholesterol reduction in just two weeks High-dose therapy led
A new oral PCSK9 inhibitor, enlicitide, offers a daily pill option for lowering LDL-C, a key cardiovascular disease risk factor. A clinical trial...
Novo Nordisk dropped the price of its injectable weight-loss drugs Wegovy and Ozempic recently. But guess what? A recent study suggests a common...
Novo Nordisk dropped the price of its injectable weight-loss drugs Wegovy and Ozempic recently. But guess what? A recent study suggests a common...
Rosuvastatin is a medicine many people take to lower their cholesterol. It’s one of the most commonly used drugs in a group called statins, which...
Rosuvastatin is a medicine many people take to lower their cholesterol. It’s one of the most commonly used drugs in a group called statins, which...
Scientists at EPFL in Switzerland have developed a new, non-invasive brain therapy that could help stroke patients regain their vision faster and more...
Scientists at EPFL in Switzerland have developed a new, non-invasive brain therapy that could help stroke patients regain their vision faster and more...
Oliver Chu from California first person to have the one-off treatment for Hunter syndrome
The Portfolio Diet combines specific cholesterol-lowering foods that can reduce bad cholesterol almost as effectively as statin medications.